In the ever-evolving landscape of digital imaging, where technological advancements often lead to increasingly complex ...

Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodiesLong-term outcomes and survival data for Ziihera® (zanidatamab-hrii), ...

BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...

Smartphones, both marvels of utility and sources of unintended consequences, need a basic rethinking of design principles.